Comparison of methods to analyse susceptibility of German MDR/XDR Pseudomonas aeruginosa to ceftazidime/avibactam.
Sign Up to like & getrecommendations! Published in 2019 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2019.05.001
Abstract: Ceftazidime/avibactam (CZA) is a new β-lactam/β-lactamase inhibitor combination with promising properties as avibactam can inhibit a broad range of β-lactamases (e.g. blaKPC, blaOXA-48). The objectives of this study were: (i) to assess CZA susceptibility rates;… read more here.
Keywords: ceftazidime avibactam; xdr pseudomonas; pseudomonas aeruginosa; cza ... See more keywords
XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin?
Sign Up to like & getrecommendations! Published in 2022 at "Antibiotics"
DOI: 10.3390/antibiotics11020193
Abstract: Background: Pseudomonas aeruginosa represents, among the nosocomial pathogens, one of the most serious threats, both for the severity of its clinical manifestations and its ability to develop complex profiles of resistance; Methods: we retrospectively collected… read more here.
Keywords: aeruginosa outside; pseudomonas aeruginosa; xdr; xdr pseudomonas ... See more keywords